L&T rises upon winning a large offshore contract from ONGC
L&T rises upon winning a large offshore contract from ONGC

L&T rises upon winning a large offshore contract from ONGC

This contract was signed for the seventh development phase of ONGC’s Pipeline Replacement Projects (PRP-VII).

Shruti Dahiwal Article rating: 5.0

This order win has been classified as a large contract, and its cumulative value falls within the range of Rs 2,500 crore to Rs 5,000 crore. 

Five stocks witnessing short covering
Five stocks witnessing short covering

Five stocks witnessing short covering

Short covering refers to buying back borrowed securities in order to close out an open short position at a profit or loss.

Avalokita Pandey Article rating: 3.0

List of the stocks where sell positions are being covered in the F&O segment.

Overnight Digest: Keep these stocks on your radar for January 28
Overnight Digest: Keep these stocks on your radar for January 28

Overnight Digest: Keep these stocks on your radar for January 28

HCL Technologies, Tech Mahindra, Dr Reddy’s Laboratories, TCS and Wipro were the top Nifty losers, while gainers included Axis Bank, SBI, Maruti Suzuki, Cipla and Kotak Mahindra Bank.

Shreya Chaware Article rating: 4.4

On Thursday, benchmark indices ended in red with Nifty settling below 17,200 in the highly volatile session after Federal Reserve in its policy outcome indicated interest rates hike soon.

Overnight Digest: These small caps will be in focus tomorrow
Overnight Digest: These small caps will be in focus tomorrow

Overnight Digest: These small caps will be in focus tomorrow

Ambica Agarbathies & Aroma Industries, Gujarat Ambuja Exports, PSP Projects, Sharda Cropchem, Khaitan Chemicals & Fertilizers, Signet Industries and Pearl Global Industries made a fresh 52-week high today.  

Armaan Madhani Article rating: 4.1

Benchmark indices Nifty 50 and Sensex fell by ~1 per cent, ending the session at 17,110.20 and 57,276.94.

This leading drug maker is moving northwards while the market is moving southwards. Know why?
This leading drug maker is moving northwards while the market is moving southwards. Know why?

This leading drug maker is moving northwards while the market is moving southwards. Know why?

In Q3FY22 Cipla beat the estimates with a decent revenue growth YoY and maintained strong momentum in key markets such as India, the US and South Africa.

Subramanian K Article rating: 5.0

Leading drug maker Cipla has announced its Q3 results a few days back. Ahead of the results, shares of the company got an upward momentum and gained 3.5 per cent in three trading days. Post-result, that is today it gained a decent 2.2 per cent that too when the overall market sentiment is bearish. 

Indices end lower amid volatility; IT drags; banks and media support the market
Indices end lower amid volatility; IT drags; banks and media support the market

Indices end lower amid volatility; IT drags; banks and media support the market

The benchmark index displayed a phenomenal recovery as it closed at 17,110 on the day of expiry.   

Rohit Kale Article rating: 5.0

A major supporter of the market was Nifty PSU Bank, which surged about 5.07 per cent while media and auto indices ended higher. Meanwhile, Nifty IT slipped about 3.55 per cent.   

RSS
First20372038203920402042204420452046Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList